Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Als crawled date : 2022 - 02 - 01 save search
PHX MINERALS INC. TO ANNOUNCE FISCAL 2022 FIRST QUARTER RESULTS AND HOST EARNINGS CALL ON FEB. 15, 2022
Published: 2022-02-01 (Crawled : 23:00) - prnewswire.com
PHX | $3.42 3.32% 0.0% 20K
|
Energy Minerals
|
| O: -0.84%
H: 2.53%
C: -1.27%
als results
Commercial Metals Company Announces Proposed $150M Tax-Exempt Bond Financing
Published: 2022-02-01 (Crawled : 23:00) - prnewswire.com
CMC | $55.21 -0.13% 0.0% 600K
|
Non-Energy Minerals
|
| O: 0.0%
H: 3.6%
C: 2.48%
als commercialization
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2022-02-01 (Crawled : 22:00) - crinetics.com
CRNX | $42.98 -0.07% -0.07% 620K
|
Health Technology
|
| O: 0.53%
H: 4.67%
C: -5.6%
als nasdaq grant granted
HII Completes Acceptance Sea Trials on Fort Lauderdale (LPD 28)
Published: 2022-02-01 (Crawled : 21:00) - globenewswire.com
HII | $271.66 1.05% 0.0% 350K
|
Electronic Technology
|
| O: -0.96%
H: 1.88%
C: 1.79%
als trials trial
Industrial Cleaning Chemicals Market by Ingredient Type, Product Type, and Region - Global Forecast to 2026
Published: 2022-02-01 (Crawled : 19:00) - prnewswire.com
SCL | $84.17 2.57% 0.0% 69K
|
Process Industries
|
| O: -0.72%
H: 0.01%
C: -0.51%
ECL | News | $218.16 -0.48% 0.69% 2.6M
|
Process Industries
|
| O: -0.08%
H: 1.0%
C: 0.51%
als trial
BioCryst to Present New ORLADEYO® (berotralstat) Data at 2022 American Academy of Allergy, Asthma & Immunology Annual Meeting
Published: 2022-02-01 (Crawled : 15:30) - biospace.com/
BCRX | $4.44 -1.33% -1.35% 4.7M
|
Health Technology
|
| O: 0.26%
H: 1.9%
C: -1.03%
orladeyo america als immunology
Sorrento Completes Acquisition of Virex Health, Will Commercialize Next-Generation at-Home Diagnostic Testing That Rivals PCR-Level Sensitivity for Daily Covid-19 Tests and Early Cancer Diagnosis
Published: 2022-02-01 (Crawled : 14:30) - globenewswire.com
SRNE | $0.024 -8.85% 57K
|
Health Technology
|
| O: 1.74%
H: 0.85%
C: -1.42%
diagnostic covid-19 health als acquisition covid test cancer
Arcutis Completes Enrollment of STRATUM Pivotal Phase 3 Trial of Topical Roflumilast Foam in Individuals with Seborrheic Dermatitis
Published: 2022-02-01 (Crawled : 13:00) - arcutis.com
ARQT | $9.09 -3.81% -3.96% 4.5M
|
Health Technology
|
| O: 0.8%
H: 4.53%
C: 2.51%
als dermatitis trial phase 3 enroll
Eagle Pharmaceuticals Announces Commercial Availability of PEMFEXY™
Published: 2022-02-01 (Crawled : 12:30) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 1.37%
H: 0.0%
C: 0.0%
EGRX | $4.63 3.35% 3.24% 60K
|
Health Technology
|
| O: 2.56%
H: 0.0%
C: -1.08%
als commercialization
Enanta Pharmaceuticals to Host Conference Call on February 8 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal First Quarter Ended December 31, 2021
Published: 2022-02-01 (Crawled : 12:30) - biospace.com/
ENTA | $13.28 0.38% 0.38% 140K
|
Health Technology
|
| O: 0.17%
H: 5.18%
C: 0.69%
als financial results conference results
Deciphera Pharmaceuticals to Announce Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call and Webcast on February 8, 2022
Published: 2022-02-01 (Crawled : 12:30) - biospace.com/
DCPH | $14.69 3.23% 3.13% 390K
|
Health Technology
|
| O: 6.93%
H: 3.83%
C: 3.77%
als financial results conference results
Kiora Pharmaceuticals Appoints Erin Parsons to its Board of Directors; Stephen From to Retire from Board
Published: 2022-02-01 (Crawled : 12:00) - eyegatepharma.com
KPRX | $0.502 -1.57% -1.59% 49K
|
Manufacturing
|
| O: 4.77%
H: 3.2%
C: -1.25%
als
Reviva Pharmaceuticals Announces First Patients Dosed in Pivotal Phase 3 Study and Long-Term Safety Trial Evaluating Brilaroxazine for the Treatment of Schizophrenia
Published: 2022-02-01 (Crawled : 12:00) - biospace.com/
RVPH | $3.035 0.5% 0.49% 140K
|
|
| O: 3.55%
H: 5.14%
C: 2.29%
treatment als schizophrenia trial phase 3 brilaroxazine
Non-alcoholic Steatohepatitis Clinical Trials Market Size Worth $4.2 Billion By 2030: Grand View Research, Inc.
Published: 2022-02-01 (Crawled : 11:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 3.58%
H: 0.0%
C: -1.59%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 2.5%
H: 0.0%
C: 0.0%
ICLR | $288.32 -1.2% -1.21% 640K
|
Health Technology
|
| O: 0.89%
H: 0.59%
C: 0.41%
hepatitis als trials research trial clinical trials
ALSTOM SA: Alstom to supply Belgium’s SNCB with up to 50 electric Traxx passenger locomotives
Published: 2022-02-01 (Crawled : 08:00) - globenewswire.com
AOMFF | News | $16.15 95.45% 4.7K
|
Producer Manufacturing
|
| O: 2.99%
H: 0.0%
C: -4.75%
ALSMY | News | $1.57 -1.78% 410K
|
Manufacturing
|
| O: -0.0%
H: 0.31%
C: -1.26%
als
Halsey Announces Love And Power Tour
Published: 2022-01-31 (Crawled : 00:00) - livenationentertainment.com
LYV | $89.96 0.36% 0.0% 2.5M
|
Consumer Services
|
| O: 4.72%
H: 2.2%
C: 0.88%
als ces
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
GBR | $1.42 31.48% 11.27% 990K
|
Energy Minerals
KUKE | $2.88 2.49% 7.64% 360K
|
MPLN | $0.6502 -11.74% 4.51% 2.2M
|
Finance
CXM 4 | $11.34 -0.44% 4.27% 1.7M
|
Information
PVL 4 | $1.47 -0.68% 4.08% 77K
|
Energy Minerals
OUST 4 | $7.16 2.43% 3.77% 880K
|
Manufacturing
RNR 4 | $224.74 0.85% 3.52% 310K
|
Finance
DDL | News | $1.15 6.48% 3.48% 200K
|
Retail Trade
PZG | $0.4431 0.48% 2.91% 150K
|
Non-Energy Minerals
LEV | $0.972 0.73% 2.88% 570K
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.